يعرض 1,501 - 1,520 نتائج من 21,342 نتيجة بحث عن '(( significant decrease decrease ) OR ( significantly ((nn decrease) OR (treatment decreased)) ))', وقت الاستعلام: 0.72s تنقيح النتائج
  1. 1501
  2. 1502
  3. 1503
  4. 1504
  5. 1505
  6. 1506
  7. 1507
  8. 1508

    S1 Data - حسب Jia Long (288557)

    منشور في 2024
    "…The total chlorophyll content of blueberry leaves at 25% light intensity increased by 76.4% compared with CK during the blue fruiting stage; the maximum net photosynthetic rate (Pmax), light compensation point (LCP), light saturation point (LSP), rate of dark respirations (Rd), inter-cellular CO<sub>2</sub> concentration (Ci), stomatal conductance (Gs), transpiration rate (Tr), net photosynthesis rate (Pn), and chlorophyll a/b showed a decreasing trend with decreasing light intensity. The Pn of blueberry leaves was highest under full light conditions at all three stages, and the Pn at 25% light intensity decreased by 68.5% compared with CK during the white fruiting stage Reflecting the fact that blueberries can adapt to low-light environments through increases in chlorophyll and carotenoids, but reduced light intensity significantly inhibited their photosynthesis. …"
  9. 1509

    Number of visits per clinic type, 2013-2015. حسب Jacob Dreiher (14856863)

    منشور في 2025
    "…During PE, statistically significant longer waiting times were found for surgery (+1.0 day) and imaging (+1.1 days), while a 2.4 days decrease was noted in pediatrics, controlled for age, sex, ethnicity and the daily number of visits. …"
  10. 1510
  11. 1511
  12. 1512
  13. 1513

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"
  14. 1514

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"
  15. 1515

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"
  16. 1516
  17. 1517

    Flow chart of data screening and analysis. حسب Yan She (8639796)

    منشور في 2025
    الموضوعات:
  18. 1518
  19. 1519
  20. 1520